Ledger.Open graph →
SEC Form D · filed April 29, 2016

Keros Therapeutics, Inc

Offering
$10.0M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jasbir S. Seehra · Lexington, MAExec · DirectorOhad S. Hammer · Lexington, MADirectorJulius S. Knowles · Lexington, MADirectorAlon S. Lazarus · Lexington, MADirectorRan S. Nussbaum · Lexington, MADirectorDaniel M. Freeman · London, United KingdomDirectorFrancisco J. Gonzalez · Miami, FLDirectorGeoffrey O. Kalish · New York, NYDirectorPatricia W. Seminario · Portland, ORDirectorJuan J. De Abreu Macedo · Miami, FLExec · DirectorEmil W. Henry, Jr · New York, NYDirectorAlessandro M. Boninsegna · New York, NYDirectorRichard J. Trabulsi · New York, NYDirectorKevin M. Morse · Merrillville, INExec · DirectorDean Hatton · Fort Lauderdale, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗